AMGEN Inc [AMGN] stock is trading at $271.34, down -1.33%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AMGN shares have gain 3.45% over the last week, with a monthly amount drifted -2.54%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Wolfe Research started tracking the stock assigning a Peer Perform rating. Citigroup initiated its recommendation with a Neutral and recommended $335 as its price target on November 14, 2024. Bernstein started tracking with a Outperform rating for this stock on October 17, 2024, and assigned it a price target of $380. In a note dated October 14, 2024, Truist downgraded an Hold rating on this stock and boosted its target price from $320 to $333.
AMGEN Inc [AMGN] stock has fluctuated between $253.30 and $346.85 over the past year. Currently, Wall Street analysts expect the stock to reach $304.67 within the next 12 months. AMGEN Inc [NASDAQ: AMGN] shares were valued at $271.34 at the most recent close of the market. An investor can expect a potential return of 12.28% based on the average AMGN price forecast.
Analyzing the AMGN fundamentals
AMGEN Inc [NASDAQ:AMGN] reported sales of 33.93B for the trailing twelve months, which represents a growth of 9.42%. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at 0.22%, Pretax Profit Margin comes in at 0.19%, and Net Profit Margin reading is 0.17%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.93 and Total Capital is 0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of9.24.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, AMGEN Inc’s Current Ratio is 1.17. Also, the Quick Ratio is 0.88, while the Cash Ratio stands at 0.38. Considering the valuation of this stock, the price to sales ratio is 4.30, the price to book ratio is 23.51 and price to earnings (TTM) ratio is 24.77.
Transactions by insiders
Recent insider trading involved Busch Matthew C., VP, Finance & CAO, that happened on May 02 ’25 when 1000.0 shares were sold. Officer, Busch Matthew C. completed a deal on May 02 ’25 to buy 1000.0 shares. Meanwhile, EVP, Operations Santos Esteban sold 8711.0 shares on Feb 19 ’25.
